文献速递疝与腹壁外科急腹症与外科感染围术期管理与 ERAS

生物补片与合成补片在CDC 3、4类污染腹壁重建中的结局比较

Outcomes of biologic versus synthetic mesh in CDC class 3 and 4 open abdominal wall reconstruction.
PubMed 文献 · Surg Endosc · 2022-08-04

本研究基于单中心前瞻性数据库,比较CDC 3、4类污染伤口腹壁重建中使用生物补片(335例)与合成补片(51例)的结局。结果显示两组疝复发率无显著差异,但合成补片组补片感染率(11.8% vs 1.2%)和感染相关切除率(7.8% vs 0%)显著更高,多因素分析示合成补片预测补片感染的OR为18.6。

要点

  • 污染腹壁重建中合成补片补片感染率显著高于生物补片(11.8% vs 1.2%)。
  • 伤口并发症和桥接补片是疝复发的预测因素。
  • 合成补片和伤口并发症是补片感染的预测因素。

核心结论

  • 在CDC 3、4类污染伤口腹壁重建中,伤口并发症显著增加补片感染和疝复发,未实现筋膜关闭也增加疝复发。
  • 使用合成补片较生物补片使补片感染率增加18.6倍。

研究设计与样本

  • 前瞻性单中心数据库查询,纳入386例CDC 3、4类污染伤口行腹壁重建的患者,其中生物补片335例,合成补片51例。
  • 采用多因素逻辑回归分析预测疝复发和补片感染的因素。

主要发现

  • 生物补片组疝缺损面积更大(298 ± 233 cm² vs 208 ± 155 cm²,p=0.004),复发疝比例更高(72.2% vs 47.1%,p<0.001),合并症更多(5.8 ± 2.7 vs 4.2 ± 2.4,p<0.01),CDC 4类伤口比例近五倍增加(47.8% vs 9.8%,p<0.001),筋膜关闭率有更低趋势(90.7% vs 96.1%,p=0.078)。
  • 疝复发率在生物补片与合成补片间相当(10.4% vs 17.6%,p=0.132)。
  • 伤口并发症率相似(36.1% vs 33.3%,p=0.699),但合成补片组补片感染率更高(11.8% vs 1.2%,p<0.001),感染相关切除率更高(7.8% vs 0%,p<0.001),其中66%的合成补片感染需切除。
  • 逻辑回归显示,伤口并发症(OR 5.96 [CI 1.60-22.17],p=0.008)和桥接补片(OR 13.10 [CI 2.71-63.42],p=0.030)预测疝复发;合成补片(OR 18.6 [CI 2.35-260.4],p=0.012)和伤口并发症(OR 20.6 [CI 3.15-417.7],p=0.008)预测补片感染。

临床怎么用

  • 在CDC 3、4类污染伤口腹壁重建中,需权衡合成补片较高的补片感染风险与生物补片在较大缺损中的应用。
  • 应积极预防和处理伤口并发症,并尽量实现筋膜关闭,以降低疝复发和补片感染风险。

局限性

  • 本研究为单中心前瞻性数据库查询,非随机对照,组间基线特征存在显著差异(如缺损大小、复发疝比例、合并症和伤口分级)。
  • 合成补片组样本量较小(51例),可能影响统计效能和结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Abdominal wall reconstruction (AWR) in a contaminated field is associated with an increased risk of wound complications, infection, and reoperation. The best method of repair and mesh choice in these operations have generated marked controversy. Our aim was to compare outcomes of patients who underwent AWR with biologic versus synthetic mesh in CDC class 3 and 4 wounds. METHODS: A prospective, single-institution database was queried for AWR using biologic or synthetic mesh in CDC Class 3 and 4 wounds. Hernia recurrence and complications were measured. Multivariable logistic regression was performed to identify factors predicting both. RESULTS: In total, 386 patients with contaminated wounds underwent AWR, 335 with biologic and 51 with synthetic mesh. Groups were similar in age, sex, BMI, and rate of diabetes. Biologic mesh patients had larger hernia defects (298 ± 233cm2 vs. 208 ± 155cm2; p = 0.004) and a higher rate of recurrent hernias (72.2% vs 47.1%; p < 0.001), comorbidities(5.8 ± 2.7 vs. 4.2 ± 2.4, p < 0.01), and a nearly fivefold increase in Class 4 wounds (47.8% vs. 9.8%, p < 0.001), while fascial closure trended to being less common (90.7% vs 96.1%; p = 0.078). Hernia recurrence was comparable between biologic and synthetic mesh (10.4% vs. 17.6%, p = 0.132). Wound complication rates were similar (36.1% vs. 33.3%, p = 0.699), but synthetic mesh had higher rates of mesh infection (1.2% vs 11.8%; p < 0.001) and infection-related resection (0% vs 7.8%, p < 0.001), with 66% of those synthetic mesh infections requiring excision. On logistic regression, wound complications (OR 5.96 [CI 1.60-22.17]; p = 0.008) and bridging mesh (OR 13.10 [CI 2.71-63.42];p = 0.030) predicted of hernia recurrence (p < 0.05), while synthetic mesh (OR 18.6 [CI 2.35-260.4] p = 0.012) and wound complications (OR 20.6 [CI 3.15-417.7] p = 0.008) predicted mesh infection. CONCLUSIONS: Wound complications in AWR with CDC class 3 and 4 wounds significantly increased mesh infection and hernia recurrence; failure to achieve fascial closure also increased hernia recurrence. Use of synthetic versus biologic mesh increased the mesh infection rate by 18.6 times.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Katzen M, Ayuso SA, Sacco J, et al. Outcomes of biologic versus synthetic mesh in CDC class 3 and 4 open abdominal wall reconstruction. Surg Endosc. 2022. PMID: 35925400. doi:10.1007/s00464-022-09486-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。